WebPin Therapeutics is a pharmaceutical company that creates therapeutic products based on chemical biology-driven protein degradation, including PROTAC technology. The company aims to develop PROTAC compounds for oncology, neurodegenerative diseases, and cardiovascular indications based on disease-agnostic approaches. F FIMECS WebFounded in 2024 Private Company "Amphista Therapeutics is the leading European targeted protein degradation (TPD) company. We have developed several completely novel mechanisms to remove disease-causing proteins with the potential to overcome many of the limitations seen with current TPD approaches.
Top FIMECS Alternatives, Competitors
WebAug 30, 2024 · Contacts. ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office ... WebAmbagon Therapeutics. Private Company. Founded 2024. USA. Ambagon applies deep knowledge of 14-3-3 proteins and a proprietary suite of drug discovery tools to create molecular glues that stabilize 14-3-3:target complexes. These molecular glue stabilizers amplify native biology to restore or inhibit target... black mountain to asheville
Pipeline - FIMECS
WebApr 10, 2024 · FIMECS, Inc. Media Contact: Yusuke Kohno, VP Corporate Development +81-466-32-1169 [email protected] Contacts FIMECS, Inc. Media Contact: Yusuke … WebAug 23, 2024 · Natural killer (NK) cells are emerging as a promising therapeutic option in cancer. To better understand how cancer cells evade NK cells, we studied interacting NK and blood cancer cells using single-cell and genome-scale functional genomics screens. WebCancer therapeutics continues to be one of the most active segments, in terms of drug development efforts, within the pharmaceutical industry. ... development (6%) and … garden bed with clay soil